Literature DB >> 7371706

Pharmacokinetic studies in man with gallamine triethiodide. II. Single 4 and 6 mg/kg i.v. doses.

M I Ramzan, E J Triggs, C A Shanks.   

Abstract

Fourteen patients undergoing elective surgery were studied at two levels of gallamine dosage. Seven patients received a single bolus dose of 4 mg/kg, and the remainder received 6 mg/kg. The venous plasma concentration-time data from both groups were characterized in terms of a two-compartment open model. No significant differences in the various pharmacokinetic parameters were noted. However the distribution and clearance terms from these two patient groups were significantly higher than those obtained with a previous group of patients receiving lower (2 mg/kg) single and multiple doses. Assessment of neuromuscular twitch response showed that maximum blockade was attained in all patients within 5 min with the time to peak effect being dose dependent. Recovery from paralysis as assessed at 99, 95 and 90% paralysis indicated that the duration of action was similarly dose dependent. The concurrently measured plasma concentrations showed wide variation but were higher at more profound levels of paralysis. Arterial blood samples for 5 patients receiving the 4 mg/kg gallamine dose were taken simultaneously with the venous samples over the first sixty minutes. No significant arterio-venous differences in gallamine plasma concentration were noted at any time interval in all subjects.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7371706     DOI: 10.1007/BF00562623

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

1.  Studies of d-tubocurarine with measurements of concentration in human blood.

Authors:  E N COHEN; W J PAULSON; B ELERT
Journal:  Anesthesiology       Date:  1957 Mar-Apr       Impact factor: 7.892

2.  Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1976-10

3.  Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT.

Authors:  P V Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

4.  [Study of pharmacokinetics of galamine in humans].

Authors:  P Duvaldestin; D Henzel; M R Gilles; C Roze; J M Desmonto
Journal:  Anesth Analg (Paris)       Date:  1977 Mar-Apr

5.  Arterial and venous plasma levels of bupivacaine following epidural and intercostal nerve blocks.

Authors:  D C Moore; L E Mather; P O Bridenbaugh; L D Bridenbaugh; R I Balfour; D F Lysons; W G Horton
Journal:  Anesthesiology       Date:  1976-07       Impact factor: 7.892

6.  Pharmacokinetic studies in man with gallamine triethiodide. I. Single and multiple clinical doses.

Authors:  M I Ramzan; E J Triggs; C A Shanks
Journal:  Eur J Clin Pharmacol       Date:  1980-02       Impact factor: 2.953

7.  A preliminary investigation of the renal and hepatic excretion of gallamine triethiodide in man.

Authors:  S Agoston; G A Vermeer; U W Kersten; A H Scaf
Journal:  Br J Anaesth       Date:  1978-04       Impact factor: 9.166

8.  Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine.

Authors:  L B Sheiner; D R Stanski; S Vozeh; R D Miller; J Ham
Journal:  Clin Pharmacol Ther       Date:  1979-03       Impact factor: 6.875

  8 in total
  4 in total

Review 1.  Clinical pharmacokinetics of neuromuscular blocking drugs.

Authors:  S Agoston; R H Vandenbrom; J M Wierda
Journal:  Clin Pharmacokinet       Date:  1992-02       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of the non-depolarising muscle relaxants.

Authors:  M I Ramzan; A A Somogyi; J S Walker; C A Shanks; E J Triggs
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

3.  Pharmacokinetic studies in man with gallamine triethiodide. I. Single and multiple clinical doses.

Authors:  M I Ramzan; E J Triggs; C A Shanks
Journal:  Eur J Clin Pharmacol       Date:  1980-02       Impact factor: 2.953

4.  Gallamine disposition in surgical patients with chronic renal failure.

Authors:  M I Ramzan; C A Shanks; E J Triggs
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.